on December 23, 2002
Published online before print December 23, 2002, doi: 10.1161/01.HYP.0000049622.07021.4F
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 23, 2002
From the Hypertension Unit, Royal North Shore Hospital, St Leonards, Australia. * To whom correspondence should be addressed. E-mail: gstokes{at}med.usyd.edu.au.
Abstract—The aortic pulse wave contour in isolated systolic hypertension often shows a prominent reflection peak, which combines with the incident wave arising from cardiac ejection so as to widen pulse pressure. We investigated the effects of an extended-release nitrate preparation and of 2 angiotensin II (AII) inhibitors (an AII receptor antagonist and an ACE inhibitor) on the aortic pulse wave contour and systemic blood pressure in hypertensive subjects with high augmentation index caused by exaggerated pulse wave reflection. Two double-blind, randomized, placebo-controlled crossover studies were carried out in a total of 16 elderly patients with systolic hypertension resistant to conventional antihypertensive therapy. In 1 study, pharmacodynamic responses to single doses of placebo, isosorbide mononitrate, eprosartan, and captopril were determined; in the other, single-dose isosorbide mononitrate and placebo were compared in subjects treated with AII inhibitors at baseline. Blood pressure was measured by sphygmomanometry and pulse wave components by applanation tonometry at the radial artery. All 3 agents were shown to decrease brachial systolic blood pressure, aortic systolic blood pressure, and aortic pulse pressure. Qualitative effects on the aortic pulse wave contour differed: augmentation index was not significantly altered by either captopril or eprosartan but was decreased (P<0.0001) by
Revised on October 17, 2002
Effects of Isosorbide Mononitrate and AII Inhibition on Pulse Wave Reflection in Hypertension
Gordon S. Stokes*;
50% of the placebo value with isosorbide mononitrate in both study groups. We propose that isosorbide mononitrate corrected the magnified wave reflection in systolic hypertension of these elderly patients by an effect that was distinct from that exercised by either acute or chronic AII inhibition.
Key words: angiotensin antagonist • antihypertensive therapy • elderly • hypertension, arterial • isosorbide mononitrate • pulse wave
This article has been cited by other articles:
 |
|
 |
|
  M. Shimizu and K. Kario Review: Role of the augmentation index in hypertension Therapeutic Advances in Cardiovascular Disease, February 1, 2008; 2(1): 25 - 35. [Abstract] [PDF]
|
|
|
|
 |
|
 J. E. Davies, Z. I. Whinnett, D. P. Francis, K. Willson, R. A. Foale, I. S. Malik, A. D. Hughes, K. H. Parker, and J. Mayet Use of simultaneous pressure and velocity measurements to estimate arterial wave speed at a single site in humans Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H878 - H885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A L Pauca, N D Kon, and M F O'Rourke Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries Heart, November 1, 2005; 91(11): 1428 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. O'Rourke and W. W. Nichols Aortic Diameter, Aortic Stiffness, and Wave Reflection Increase With Age and Isolated Systolic Hypertension Hypertension, April 1, 2005; 45(4): 652 - 658. [Full Text] [PDF]
|
|
|
|
|
|
G. S. Stokes, A. J Bune, N. Huon, and E. S. Barin Long-Term Effectiveness of Extended-Release Nitrate for the Treatment of Systolic Hypertension Hypertension, March 1, 2005; 45(3): 380 - 384. [Abstract] [Full Text] [PDF]
|
|